COAG Hemab Therapeutics Holdings, Inc.

Fundamentals / CIK 0002114044 / USD

Hemab Therapeutics Holdings, Inc. reported $442.7M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open COAG in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for COAG.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $24.64M $20.34M $19.46M $14.55M $12.87M $14.10M
Selling, General & Admin $5.12M $5.74M $4.15M $2.50M $3.18M $2.46M
Total Operating Expenses $29.76M $26.08M $23.61M $17.05M $16.06M $16.56M
Operating Income -$29.76M -$26.08M -$23.61M -$17.05M -$16.06M -$16.56M
EBITDA -$29.68M -$26.00M -$23.54M -$16.98M -$15.98M -$16.48M
Interest Income $3.38M $2.86M $1.22M $215K $335K $473K
Income Before Tax -$26.61M -$24.05M -$22.68M -$16.97M -$12.21M -$15.50M
Income Tax Expense $693K $97K $12K $98K $4.0K -$190K
Net Income -$27.30M -$24.15M -$22.69M -$17.07M -$12.21M -$15.31M
Basic EPS -$0.58 -$0.80 -$1.09 -$18.04 -$12.91 -$0.74
Diluted EPS -$0.58 -$0.80 -$1.09 -$18.04 -$12.91 -$0.74
Basic Shares Outstanding 46.7M 30.1M 20.8M 946.0K 946.0K 20.8M
Diluted Shares Outstanding 46.7M 30.1M 20.8M 946.0K 946.0K 20.8M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for COAG.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $239.1M $237.4M $49.86M $87.97M
Short-Term Investments $191.1M $220.1M $113.7M $97.51M
Cash & Short-Term Investments $430.2M $457.5M $163.5M $185.5M
Total Current Assets $438.2M $464.0M $169.4M $192.6M
Property, Plant & Equipment, Net $555K $596K $648K $609K
Other Non-Current Assets $3.15M $2.29M $4.24M $531K
Total Non-Current Assets $4.55M $3.78M $5.83M $2.23M
Total Assets $442.7M $467.8M $175.3M $194.8M
Accounts Payable $5.95M $6.23M $5.68M $5.73M
Other Current Liabilities $1.20M $990K $2.66M $340K
Total Current Liabilities $12.94M $12.94M $13.19M $10.68M
Total Non-Current Liabilities $503K $566K $519K $573K
Total Liabilities $13.44M $13.51M $13.71M $11.25M
Total Debt (incl. Leases) $965K $1.03M $1.06M $1.22M
Retained Earnings -$256.0M -$228.7M -$204.5M -$181.9M
Accumulated Other Comp. Income -$2.65M -$2.75M -$439K $175K
Total Stockholders' Equity $429.3M $454.3M -$198.6M -$176.6M
Total Equity $429.3M $454.3M -$198.6M -$176.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for COAG.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$27.30M -$24.15M -$22.69M -$17.07M -$12.21M -$15.31M
Depreciation & Amortization $75K $75K $73K $76K $77K $75K
Change in Payables -$280K $550K -$52K $872K -$2.32M $2.88M
Operating Cash Flow -$28.29M -$22.64M -$21.58M -$16.39M -$15.33M -$13.03M
Capital Expenditure -$34K -$23K -$112K $0 $0 -$16K
Free Cash Flow -$28.32M -$22.66M -$21.70M -$16.39M -$15.33M -$13.05M
Purchases of Investments $0 -$132.5M -$15.73M $0 $0 -$19.95M
Investing Cash Flow $30.10M -$107.4M -$15.85M $0 $21.50M -$5.99M
Financing Cash Flow $47K $317.6M -$460K -$30K -$30K -$29K
Net Change in Cash $1.78M $187.5M -$38.11M -$16.43M $6.14M -$19.06M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for COAG.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 33.86x 35.85x 12.85x -- -- --
Quick Ratio 33.25x 35.34x 12.40x -- -- --
Debt to Equity 0.00x 0.00x -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002114044) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:24 UTC · Open in terminal